266 related articles for article (PubMed ID: 30001530)
1. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload.
Zong J; Li FF; Liang K; Dai R; Zhang H; Yan L; Liu JL; Xu LH; Qian WH
Cell Physiol Biochem; 2018; 48(1):75-86. PubMed ID: 30001530
[TBL] [Abstract][Full Text] [Related]
2. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Wang Z; Gao L; Xiao L; Kong L; Shi H; Tian X; Zhao L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30242058
[TBL] [Abstract][Full Text] [Related]
3. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
Ma Q; Liu Y; Chen L
Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
6. Smad Nuclear Interacting Protein 1 Acts as a Protective Regulator of Pressure Overload-Induced Pathological Cardiac Hypertrophy.
Lu YY; Xu DC; Zhao YF; Zhu GF; Zhu MY; Liu WJ; Yu XJ; Chen W; Liu Z; Xu YW
J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912208
[TBL] [Abstract][Full Text] [Related]
7. RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice.
Zhao CH; Ma X; Guo HY; Li P; Liu HY
Biochem Biophys Res Commun; 2017 Nov; 493(2):1151-1158. PubMed ID: 28698147
[TBL] [Abstract][Full Text] [Related]
8. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
9. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1.
Zhang X; Zhang MC; Wang CT
Biochem Biophys Res Commun; 2018 Nov; 506(1):137-144. PubMed ID: 30340835
[TBL] [Abstract][Full Text] [Related]
10. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
12. Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload.
Zhou H; Shen DF; Bian ZY; Zong J; Deng W; Zhang Y; Guo YY; Li H; Tang QZ
PLoS One; 2011; 6(10):e26744. PubMed ID: 22053207
[TBL] [Abstract][Full Text] [Related]
13. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic Reticulum Stress-Induced NLRP1 Inflammasome Activation Contributes to Myocardial Ischemia/Reperfusion Injury.
Cao L; Chen Y; Zhang Z; Li Y; Zhao P
Shock; 2019 Apr; 51(4):511-518. PubMed ID: 30286036
[TBL] [Abstract][Full Text] [Related]
16. Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.
Xu T; Tang H; Zhang B; Cai C; Liu X; Han Q; Zou L
Int J Clin Exp Pathol; 2015; 8(1):530-40. PubMed ID: 25755743
[TBL] [Abstract][Full Text] [Related]
17. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.
Takano APC; Munhoz CD; Moriscot AS; Gupta S; Barreto-Chaves MLM
J Mol Med (Berl); 2017 Jun; 95(6):671-682. PubMed ID: 28161820
[TBL] [Abstract][Full Text] [Related]
18. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
19. NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload.
Zong J; Salim M; Zhou H; Bian ZY; Dai J; Yuan Y; Deng W; Zhang JY; Zhang R; Wu QQ; Tang QZ
Lab Invest; 2013 Oct; 93(10):1128-36. PubMed ID: 23958879
[TBL] [Abstract][Full Text] [Related]
20. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
